Fig. 2From: Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancerKaplan-Meier estimates of (a) Locoregional progression free survival (LRPFS) and (b) overall survival (OS), according to total dose ≥45 Gy or < 45 GyBack to article page